Viveon Health Acq CRP (VHAQ) Stock News, Jan 12, 2022

Suneva Medical, an innovative firm in regenerative aesthetics, has announced a merger agreement with Viveon Health Acquisition Corp (NYSE: VHAQ). The merger, expected to close in the first half of 2022, aims to leverage Suneva's patented products to meet the growing demand in the $11 billion regenerative aesthetics market. The pro forma equity valuation of the combined company is projected at $511 million, with potential share earn-outs tied to performance metrics. Both companies emphasize enhancing shareholder value and expanding market reach through this partnership.